SLOAD: a comprehensive database of cancer-specific synthetic lethal interactions for precision cancer therapy via

Li Guo1, Yuyang Dou1, Daoliang Xia1

  • 1Department of Bioinformatics, Smart Health Big Data Analysis and Location Services Engineering Lab of Jiangsu Province, School of Geographic and Biologic Information, Nanjing University of Posts and Telecommunications, No. 9, Wenyuan Road, Qixia District, Nanjing, Jiangsu 210023, China.

Insights

Synthetic lethality offers a promising cancer treatment strategy by targeting inactive genes. This study predicts cancer-specific synthetic lethal interactions using multi-omics data and random forest, creating a valuable database for drug discovery.

Area of Science:

  • Oncology
  • Genetics
  • Bioinformatics

Background:

  • Synthetic lethality is a key strategy for cancer therapy, selectively targeting cancer cells by exploiting gene inactivation.
  • Identifying cancer-specific synthetic lethal interactions is crucial for developing effective targeted therapies.

Purpose of the Study:

  • To predict cancer-specific synthetic lethal interactions using a pan-cancer analysis.
  • To develop a user-friendly database (SLOAD) for accessing these predicted interactions.

Main Methods:

  • Integration of multi-omics data (DNA mutation, copy number variation, methylation, mRNA expression).
  • Application of random forest machine learning models for predicting genetic interactions.
  • Development of the SLOAD database for data management and analysis.

Main Results:

  • Successfully predicted numerous candidate cancer-specific synthetic lethal interactions.
  • Established SLOAD, a comprehensive and user-friendly database for synthetic lethality research.
  • The database facilitates searching, browsing, downloading, and analyzing predicted interactions.

Conclusions:

  • The predicted interactions and SLOAD database provide valuable resources for cancer drug design.
  • This work advances synthetic lethality-based therapeutic strategies.
  • Enables further research into targeted cancer treatments.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.1K